About Icoria
Icoria is a Healthcare company based in Durham (United States) founded in 1997, and was acquired by Timeline Logistics in September 2005. Provider of software tools for genomics. It operates in the Healthcare and Technology sectors. Icoria has raised $33 million across 3 funding rounds from investors including National Oceanic and Atmospheric Administration and Timeline Logistics. The company was acqui-hired. Its focus areas include High Tech, Computer Vision, Industry Specific Applications and Health Care. Its competitors include Helix, Benchling and Genuity Science; 3 of its 3 listed competitors have raised funding.
Company details
Icoria is a biotechnology company dedicated to finding new ways of detecting and treating human disease. The Company uses its ability to analyze biological function at the level of gene expression, biochemical pathways and tissue structure to discover and validate biomarkers, drugs and drug targets. It works with pharmaceutical, biotechnology, government and academic laboratories on a fee for service or collaborative basis, while it develops its own sets of products for internal development, or eventual out-licensing. Icorias computer vision tissue analysis software enables the imaging and analysis of complete tissue sections in an automated fashion, providing a mechanism for improving throughput and productivity of early-stage toxicology studies in the drug development process, as well as providing better information. It was earlier known as Paradigm Genetics. It was acquired by Cogenics in Jul 2006. Metabolon acquired metabolomics-related intellectual property from Cogenics Icoria in Oct 2007.
- Headquarters Durham, United States
- Stage Acquired
- SectorsHealthcareTechnology
- Website icoria.com
- Acquired by Timeline Logistics (Sep 2005)
- Total Equity Funding$33M (USD)
in 3 rounds
- Latest Funding Round$5M (USD), Series A
Oct 2004
- Investors
- Acquired byTimeline Logistics
(Sep 2005)
Funding Insights of Icoria
Icoria has successfully raised a total of $33M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in October 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $33M
- Total Rounds 3
- Last Round Series A — $5M
- First Round $28M
(Oct 2001)
- Investors Count 1
All 3 funding rounds of Icoria with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2004 | $5M | Series A | – | – | – |
| May 2002 | $11.4M | Grant | – | – | |
| Oct 2001 | $28M | Series A | – | – | – |
2 investors in total: 2 institutional.
Investors in Icoria
Icoria has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include National Oceanic and Atmospheric Administration and Timeline Logistics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| noaa.gov | ||||
Timeline Logistics is engaged in providing delivery and warehousing services in Texas. | 2005 | timelinelogistics.com | Houston, United States |
Investor details for Icoria
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Icoria
4 dated milestones of Icoria across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Icoria is founded.
- Funding First funding round of $28.0M.
- Funding Latest funding round, Series A, of $5.0M.
- Exit Acquired by Timeline Logistics.
Competitors of Icoria
Icoria has 3 listed competitors in our database, 3 of them funded. They include Helix, Benchling and Genuity Science.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helix.com | 2015 | San Francisco, United States | $435M | Genomic database for clinical research is provided. | ||
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. | |
| genuitysci.com | 2013 | Boston, United States | $515M | AI-based omics data analysis solutions are provided to researchers. |
Detailed competitors of Icoria
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Icoria (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Icoria
Icoria was founded in 1997 and raised its 1st funding round 4 years after it was founded.
Icoria is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Icoria is a funded company, having raised a total of $33M across 3 funding rounds to date. The company's 1st funding round was a Series A of $28M, raised on Oct 2001.
Icoria is a biotechnology company dedicated to finding new ways of detecting and treating human disease. The Company uses its ability to analyze biological function at the level of gene expression, biochemical pathways and tissue structure to discover and validate biomarkers, drugs and drug targets. It works with pharmaceutical, biotechnology, government and academic laboratories on a fee for service or collaborative basis, while it develops its own sets of products for internal development, or eventual out-licensing. Icorias computer vision tissue analysis software enables the imaging and analysis of complete tissue sections in an automated fashion, providing a mechanism for improving throughput and productivity of early-stage toxicology studies in the drug development process, as well as providing better information. It was earlier known as Paradigm Genetics. It was acquired by Cogenics in Jul 2006. Metabolon acquired metabolomics-related intellectual property from Cogenics Icoria in Oct 2007.
Icoria's top competitors include Helix, Benchling and Genuity Science.
Icoria has 2 investors. Key investors include National Oceanic and Atmospheric Administration, and Timeline Logistics.
Yes. Icoria was acquired by Timeline Logistics in September 2005.